Monarch eTNS  for non-pharmalogical  ADHD treatment 

A New Solution for ADHD

Many parents are hesitant to start their young children on stimulant medications due to side effects or stigma.

Now you can offer an alternative: Monarch eTNS®, a noninvasive neuromodulation therapy developed at UCLA and funded by NIH, which helps regulate key brain regions linked to ADHD – without medication.

Non-Pharmacological: Uses mild nerve stimulation instead of drugs.
 

At-Home Use: Administered by caregivers during sleep – no clinic visits or monitoring required.
 

Proven Efficacy: Significant symptom improvement in 4 weeks¹ ² (per clinical trial)

Minimal Side Effects: No serious adverse events, only mild transient effects¹ ² (e.g. drowsiness)